Dr. Andrew Yue Lin Li, MD

Dr. Li practices at Maryland Oncology Hematology, P.A. in Frederick, Maryland.

Dr. Li's NPI, 1780189704, was assigned on March 30, 2018. Dr. Li holds Maryland license D0099266.

Dr. Li's primary practice is Maryland Oncology Hematology, P.A., at 46 B Thomas Johnson Dr, Frederick, MD 21702 in Frederick County. The practice phone is (301) 695-6777.

Dr. Li's primary practice is Maryland Oncology Hematology, P.A. in Frederick, Maryland. Dr. Li is also affiliated with Frederick Health Hospital. The medical group on file is Meritus Radiology. Dmand AI also links Dr. Li to 1 more hospital, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Li practices, 5 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Li's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Li is licensed in Maryland.

CMS data shows 19,578 Medicare services from Dr. Li across 27 procedure codes in 2024, for 408 Medicare patients. Medicare paid $203,945 for them.

CMS counts 408 Medicare patients who saw Dr. Li in 2024. The largest group is 65 to 74, with 164 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 12% are also on Medicaid. Their average risk score is 1.83, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Li's median patient age at 67, with 61% women.

In 2024, Dr. Li wrote 154 Medicare Part D claims for 46 patients. 86% of them were for generic drugs. CMS names the drug for 32 of them, across 2 drugs with 11 or more claims each, at $252 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Li for performance year 2024, reported as part of a group. Dr. Li accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Li as offering telehealth.

Dmand AI links 20 papers to Dr. Li, published from 2014 to 2024. 2020 was the busiest year, with 4. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Brain and Cells, Cultured. Dr. Li has published most often in Metabolites. Dr. Li's most frequent co-authors are Maria R. Baer, MD, Vu H. Duong, MD and Ashkan Emadi, MD, PhD.

CMS Open Payments shows 148 general payments to Dr. Li from 50 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $425.